What biomarkers (if any) for precise medicine?
作者信息
Strano Sabrina, Muti Paola, Blandino Giovanni
机构信息
Regina Elena National Cancer Institute, Rome, Italy.
Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
出版信息
Aging (Albany NY). 2015 Aug;7(8):533-4. doi: 10.18632/aging.100798.
Abstract
摘要
相似文献
1
What biomarkers (if any) for precise medicine?精准医学的生物标志物（若存在）有哪些？
Aging (Albany NY). 2015 Aug;7(8):533-4. doi: 10.18632/aging.100798.
2
Personalizing the Attack on Cancer: Zeroing in on Targets.个性化抗癌策略：聚焦靶点
Cancer Control. 2015 Apr;22(2):133-5. doi: 10.1177/107327481502200201.
3
Biomarkers: exceptional responders-discovering predictive biomarkers.生物标志物：卓越应答者——发现预测性生物标志物
Nat Rev Clin Oncol. 2015 Mar;12(3):132-4. doi: 10.1038/nrclinonc.2015.19. Epub 2015 Feb 17.
4
Promise of Precision Medicine in Cancers: Lessons Learned.癌症精准医学的前景：经验教训
S D Med. 2017 Nov;70(11):486-490.
5
Precision Medicine: Implications for Science and Practice.精准医学：对科学与实践的影响。
J Am Coll Surg. 2016 Sep;223(3):433-439.e1. doi: 10.1016/j.jamcollsurg.2016.05.020. Epub 2016 Jun 16.
引用本文的文献
1
Using bioinformatics approaches to investigate driver genes and identify BCL7A as a prognostic gene in colorectal cancer.使用生物信息学方法研究驱动基因并将BCL7A鉴定为结直肠癌的一个预后基因。
Comput Struct Biotechnol J. 2021 Jul 1;19:3922-3929. doi: 10.1016/j.csbj.2021.06.044. eCollection 2021.
2
Circular RNAs and their roles in head and neck cancers.环状 RNA 及其在头颈部癌症中的作用。
Mol Cancer. 2019 Mar 21;18(1):44. doi: 10.1186/s12943-019-1003-5.
3
MiRNA-513a-5p inhibits progesterone receptor expression and constitutes a risk factor for breast cancer: the hOrmone and Diet in the ETiology of breast cancer prospective study.miRNA-513a-5p 抑制孕激素受体表达并构成乳腺癌的危险因素：乳腺癌病因的激素与饮食前瞻性研究。
Carcinogenesis. 2018 Feb 9;39(2):98-108. doi: 10.1093/carcin/bgx126.
本文引用的文献
1
Translating genomics for precision cancer medicine.将基因组学转化用于精准癌症医学。
Annu Rev Genomics Hum Genet. 2014;15:395-415. doi: 10.1146/annurev-genom-090413-025552.
2
Comprehensive molecular profiling of lung adenocarcinoma.肺腺癌的全面分子分析。
Nature. 2014 Jul 31;511(7511):543-50. doi: 10.1038/nature13385. Epub 2014 Jul 9.
3
Downregulation of microRNAs 145-3p and 145-5p is a long-term predictor of postmenopausal breast cancer risk: The ORDET prospective study.微小RNA 145-3p和145-5p的下调是绝经后乳腺癌风险的长期预测指标：ORDET前瞻性研究。
Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2471-81. doi: 10.1158/1055-9965.EPI-14-0398. Epub 2014 Jul 29.
4
Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.TP53 突变相关 microRNAs 的表达预测头颈部鳞状细胞癌患者的临床结局。
Ann Oncol. 2013 Dec;24(12):3082-8. doi: 10.1093/annonc/mdt380. Epub 2013 Oct 9.
5
The locus of microRNA-10b: a critical target for breast cancer insurgence and dissemination.miR-10b 的作用位点：乳腺癌侵袭和转移的关键靶点
Cell Cycle. 2013 Aug 1;12(15):2371-5. doi: 10.4161/cc.25380. Epub 2013 Jun 26.
6
Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer.体内靶向 p53：一种在难治性血液系统恶性肿瘤和前列腺癌中进行的 p53 靶向化合物 APR-246 的首次人体研究。
J Clin Oncol. 2012 Oct 10;30(29):3633-9. doi: 10.1200/JCO.2011.40.7783. Epub 2012 Sep 10.
Zotero 插件